Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 17 04:00PM ET
101.14
Dollar change
-1.36
Percentage change
-1.33
%
IndexRUT P/E577.28 EPS (ttm)0.18 Insider Own3.48% Shs Outstand5.37M Perf Week-2.80%
Market Cap545.14M Forward P/E12.41 EPS next Y8.15 Insider Trans-0.79% Shs Float5.21M Perf Month-0.57%
Income0.95M PEG- EPS next Q1.91 Inst Own90.24% Short Float3.67% Perf Quarter9.58%
Sales212.87M P/S2.56 EPS this Y-7.52% Inst Trans-1.50% Short Ratio4.15 Perf Half Y2.21%
Book/sh74.70 P/B1.35 EPS next Y5.80% ROA0.13% Short Interest0.19M Perf Year-40.39%
Cash/sh5.24 P/C19.32 EPS next 5Y- ROE0.24% 52W Range82.86 - 178.64 Perf YTD-3.46%
Dividend Est.- P/FCF13.39 EPS past 5Y- ROI0.15% 52W High-43.38% Beta0.83
Dividend TTM0.64 (0.63%) Quick Ratio1.86 Sales past 5Y21.10% Gross Margin50.42% 52W Low22.06% ATR (14)4.68
Dividend Ex-DateMay 31, 2024 Current Ratio2.68 EPS Y/Y TTM162.34% Oper. Margin0.23% RSI (14)45.07 Volatility3.84% 4.62%
Employees698 Debt/Eq0.59 Sales Y/Y TTM-4.27% Profit Margin0.45% Recom1.67 Target Price130.00
Option/ShortNo / Yes LT Debt/Eq0.58 EPS Q/Q366.23% Payout368.88% Rel Volume0.66 Prev Close102.50
Sales Surprise-2.60% EPS Surprise13.06% Sales Q/Q-1.50% EarningsFeb 05 BMO Avg Volume45.99K Price101.14
SMA20-2.80% SMA50-2.42% SMA200-6.91% Trades Volume30,554 Change-1.33%
Date Action Analyst Rating Change Price Target Change
Jan-04-24Upgrade Evercore ISI In-line → Outperform $100 → $125
Jan-04-21Downgrade Evercore ISI Outperform → In-line $300
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $287
Oct-02-20Initiated JP Morgan Neutral $260
Dec-04-19Initiated Jefferies Buy
Aug-26-19Initiated Evercore ISI Outperform $250
Jun-10-16Downgrade Sidoti Buy → Neutral
Apr-08-24 08:00AM
Apr-04-24 06:24PM
Apr-01-24 10:27AM
Mar-15-24 07:00AM
Feb-19-24 10:23AM
09:20AM Loading…
Feb-05-24 09:20AM
08:36AM
08:22AM
08:00AM
Jan-08-24 08:00AM
Jan-04-24 03:00PM
Jan-03-24 08:00AM
Dec-14-23 10:47AM
Nov-06-23 09:10AM
08:13AM
08:00AM Loading…
08:00AM
Oct-16-23 03:00AM
Oct-03-23 08:00AM
Sep-22-23 08:09AM
06:20AM
Sep-15-23 01:10AM
Sep-13-23 01:37PM
Sep-11-23 11:21AM
Aug-24-23 04:02PM
Aug-10-23 01:32AM
Aug-03-23 09:35AM
08:27AM
08:00AM
Jul-31-23 07:50AM
Jul-05-23 03:00PM
08:00PM Loading…
Jun-21-23 08:00PM
11:50AM
May-25-23 09:25AM
08:14AM
08:00AM
May-22-23 01:16PM
May-02-23 06:23AM
Apr-26-23 08:00PM
Apr-03-23 06:15PM
06:00PM
07:42AM
Mar-13-23 08:00AM
Mar-09-23 08:00AM
Feb-21-23 05:36AM
Feb-14-23 09:00AM
Feb-13-23 12:45PM
08:00AM
Feb-06-23 09:55AM
08:36AM
Feb-01-23 12:43PM
06:43AM
Jan-27-23 06:00PM
Jan-19-23 06:15PM
Jan-17-23 04:33PM
Jan-13-23 06:00PM
Jan-12-23 09:40AM
Jan-11-23 06:26AM
Jan-09-23 06:15PM
Jan-03-23 05:00PM
Dec-28-22 06:51AM
05:20AM
Dec-18-22 04:48PM
Dec-16-22 11:59AM
Nov-23-22 12:20PM
Nov-17-22 08:04AM
Nov-08-22 06:48AM
Nov-04-22 03:49PM
Nov-03-22 10:25AM
08:00AM
Oct-25-22 06:32AM
Oct-03-22 02:00PM
Sep-11-22 08:33AM
Aug-04-22 11:05AM
08:00AM
Jul-28-22 10:03AM
Jul-06-22 07:00PM
Jun-27-22 08:01AM
May-31-22 09:25AM
08:00AM
May-13-22 10:17AM
Apr-12-22 09:51AM
Apr-06-22 01:10PM
Apr-04-22 12:02PM
Feb-03-22 09:25AM
09:11AM
08:00AM
Jan-26-22 03:01PM
Jan-06-22 03:00PM
Dec-21-21 08:01AM
07:12AM
Dec-20-21 12:48PM
07:52AM
Dec-16-21 10:47AM
05:20AM
Dec-11-21 09:15AM
Nov-04-21 10:55AM
08:00AM
Oct-29-21 08:00AM
Oct-28-21 03:05PM
Oct-21-21 09:35AM
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Archbold Brian DavidSVP OperationsDec 15 '23Sale112.361,500168,540558Dec 19 11:21 AM
Schmieder John BradleyDirectorSep 15 '23Sale123.741,000123,74062,760Sep 19 12:34 PM
Schmieder John BradleyDirectorSep 14 '23Sale123.053,000369,15063,760Sep 19 12:34 PM
Schmieder John BradleyDirectorSep 13 '23Sale123.323,000369,96566,760Sep 14 01:47 PM
Owens Gary MPresident and CEOSep 01 '23Option Exercise136.422,000272,84032,032Sep 05 04:34 PM
Owens Gary MPresident and CEOSep 01 '23Sale142.822,000285,64030,032Sep 05 04:34 PM
Hall ShannonDirectorAug 15 '23Option Exercise0.0075401,711Aug 16 02:03 PM
Sullivan John JamesDirectorAug 15 '23Option Exercise0.00754029,004Aug 16 03:37 PM
Alltoft Jennifer SadieDirectorAug 15 '23Option Exercise0.0075402,400Aug 16 03:28 PM
Schmieder John BradleyDirectorAug 15 '23Option Exercise0.00754069,760Aug 16 03:19 PM
Tripeny R TonyDirectorAug 15 '23Option Exercise0.001,10501,605Aug 16 03:54 PM
Ladiwala Shiraz ShabanaliDirectorAug 15 '23Option Exercise0.001,05501,460Aug 16 03:45 PM
Ladiwala Shiraz ShabanaliDirectorAug 15 '23Option Exercise0.004001,500Sep 06 12:36 PM
Sullivan John JamesDirectorJun 16 '23Option Exercise0.0015028,256Jun 21 01:38 PM
Owens Gary MPresident and CEOJun 16 '23Option Exercise0.002,820030,992Jun 21 01:22 PM
Archbold Brian DavidSVP OperationsJun 16 '23Option Exercise0.0061202,247Jun 21 12:23 PM
Sakys JohnCFOJun 16 '23Option Exercise0.00848011,019Jun 21 12:02 PM
Sullivan John JamesDirectorJun 15 '23Option Exercise0.0015028,247Jun 16 07:56 PM
Owens Gary MCEOJun 15 '23Option Exercise0.002,823029,409Jun 16 07:37 PM
Archbold Brian DavidSVP OperationsJun 15 '23Option Exercise0.0061401,918Jun 16 07:10 PM
Sakys JohnCFOJun 15 '23Option Exercise0.00848010,544Jun 16 06:24 PM
Schmieder John BradleyDirectorJun 15 '23Option Exercise0.0030069,006Jun 16 07:46 PM